SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (2004)10/2/1997 12:28:00 PM
From: Henry Niman   of 6136
 
Izzy,My background is scientific(Ph.D.Biochemisty) not financial (no formal training), so I don't think that equity holdings would do much for my credibility. I recommend LGND as a long term play, but I do get a bottle of wine if it sets an all time high ($20) this year :-).
It's major move will be on a diabetes deal. The clinicals will help (mostly in the cancer area), but the diabetes deal will be the big news for LGND (which I expect any day now).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News